0001698998-24-000001.txt : 20240311 0001698998-24-000001.hdr.sgml : 20240311 20240311163534 ACCESSION NUMBER: 0001698998-24-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240307 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Woolson Daniel CENTRAL INDEX KEY: 0001698998 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 24738592 MAIL ADDRESS: STREET 1: ICU MEDICAL, INC., 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-03-07 0 0000883984 ICU MEDICAL INC/DE ICUI 0001698998 Woolson Daniel 951 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 VP, GM-Infusion Capital 0 Common Stock 2024-03-07 4 M 0 966 0.0 A 10843 D Common Stock 2024-03-07 4 F 0 426 105.39 D 10417 D Common Stock 2024-03-07 4 M 0 5792 0.0 A 16209 D Common Stock 2024-03-07 4 F 0 2564 105.39 D 13645 D Common Stock 2024-03-08 4 M 0 2020 0.0 A 15665 D Common Stock 2024-03-08 4 F 0 894 104.52 D 14771 D Common Stock 0.0 2024-03-07 4 M 0 966 0.0 D 2023-03-07 2025-03-07 Common Stock 966 966 D Common Stock 2024-03-08 4 A 0 6459 0.0 A Common Stock 6459 6459 D Performance Shares 0.0 2024-03-07 4 M 0 5792 0.0 D 2024-03-07 Common Stock 5792 0 D Performance Shares 0.0 2024-03-08 4 M 0 2020 0.0 D 2023-03-08 2024-03-08 Common Stock 2020 0 D These securities are Restricted Stock Units. These Securities are Performance-based Restricted Stock Units (PRSU). There is neither a purchase price nor an exercise price for the Restricted Stock Units. One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These are restricted stock units that fully vest 3 years from the grant date. There is neither a purchase price nor an exercise price for the PRSUs. These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant. These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant. By: Paula Darbyshire, Attorney-in-fact For: Daniel Woolson 2024-03-11